Oesophageal Cancer Trial, Recruiting NCT04522687 Sponsor: Shanghai Cancer Hospital, China Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT04522687
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People with a general health status rated as fully active or restricted only in physically strenuous activity (this is measured using a standard scale called ECOG Performance Status 0–1)
  • People who have been formally diagnosed with non-small cell lung cancer, esophageal squamous cell carcinoma, or a thymic epithelial tumour
  • People expected to live for more than 3 months
  • People who, in the treating doctor's opinion, do not currently need palliative radiotherapy
  • People who have had previous surgery, provided they have recovered adequately from it
  • People who agree to provide fresh tumour biopsy samples before and during the treatment
  • Women who could become pregnant, and men, who agree to use effective contraception throughout the trial
  • People whose blood, liver, and kidney test results meet specific minimum levels within one week before enrolling (confirm with trial site for exact values)

Who may not be able to join:

  • Women who are pregnant or breastfeeding
  • People who have a history of any other cancer
  • People who, in the treating doctor's opinion, need palliative radiotherapy
  • People with an active infection, heart failure, a heart attack within the past 6 months, unstable chest pain, or irregular heart rhythms
  • People who have previously received a tumour vaccine, or who have received a live or weakened vaccine within the 4 weeks before treatment is due to start
  • People with mental health conditions, drug misuse issues, or social circumstances that the treating doctor believes may affect their ability to follow the trial requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Cancer Hospital, China
Registry
ClinicalTrials.gov
Start date
1 January 2012
Est. completion
1 December 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov